Tempus AI Faces Class Action Lawsuits Over Genetic Data Misuse

• •Tempus AI is facing class action lawsuits for unauthorized genetic data disclosures.
• •The data in question was sourced from Ambry Genetics Corporation.
• •The lawsuits could have significant legal and operational implications for Tempus AI.

Tempus AI, a healthcare AI firm, is embroiled in multiple class action lawsuits alleging unlawful disclosures of genetic data. The lawsuits claim that Tempus AI improperly collected and disclosed genetic testing results sourced from Ambry Genetics Corporation. These actions reportedly occurred during the training of Tempus AI's machine learning models using Ambry's genetic database. Individuals whose genetic data was allegedly misused are directly affected, raising concerns about privacy violations and data security. The lawsuits highlight significant legal implications for Tempus AI and could impact its operations and reputation. As of now, the company has not publicly commented on the ongoing litigation. The scope of the lawsuits suggests a large number of affected individuals, though specific figures have not been disclosed. The situation is developing, and further legal actions may follow as more details emerge.